Zobrazeno 1 - 10
of 111
pro vyhledávání: '"David H Collier"'
Autor:
Vibeke Strand, Ervant J Maksabedian Hernandez, Bradley S Stolshek, Lyrica X H Liu, David H Collier, Gregory Kricorian
Publikováno v:
RMD Open, Vol 7, Iss 1 (2021)
Objectives We examined patient-reported outcomes (PROs) in The Study of Etanercept And Methotrexate in Patients with Psoriatic Arthritis (PsA); a 48-week, phase 3, randomised controlled trial that compared outcomes with methotrexate (MTX) monotherapy
Externí odkaz:
https://doaj.org/article/cddd1c3819a245839e9b239f459eb3f3
Autor:
Brian C. Sauer, Wei Chen, Yizhe Xu, Jincheng Shen, Neil A. Accortt, David H. Collier, Grant W. Cannon
Publikováno v:
Arthritis Research & Therapy, Vol 22, Iss 1, Pp 1-10 (2020)
Abstract Background A previous analysis of the Veterans Affairs Rheumatoid Arthritis (VARA) registry showed that more than half of the patients with rheumatoid arthritis (RA) did not receive a major therapeutic change (MTC) despite moderate or severe
Externí odkaz:
https://doaj.org/article/48dfa7dc6113451d8fdc9788aebe9567
Autor:
Jeffrey R, Curtis, Bradley, Stolshek, Paul, Emery, Boulos, Haraoui, Elaine, Karis, Greg, Kricorian, David H, Collier, Priscilla K, Yen, Vivian P, Bykerk
Publikováno v:
JCR: Journal of Clinical Rheumatology. 29:16-22
The effect of treatment withdrawal on patient-reported outcomes (PROs) in patients with rheumatoid arthritis (RA) whose disease is in sustained remission has not been well described. This analysis aimed to compare PRO changes in patients with RA foll
Autor:
George W. Reed, David H. Collier, Andrew S. Koenig, Katherine C. Saunders, Dimitrios A. Pappas, Heather J. Litman, Joel M. Kremer, Sameer Kotak
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-8 (2017)
Abstract Background We examined models to predict disease activity transitions from moderate to low or severe and associated factors in patients with rheumatoid arthritis (RA). Methods Data from RA patients enrolled in the Corrona registry (October 2
Externí odkaz:
https://doaj.org/article/15ba95ac9b944dc89ed9cf857cda8def
Publikováno v:
Arthritis Care & Research. 73:964-974
OBJECTIVE To examine the impact of major therapeutic change (MTC) on clinical response across a broad range of disease activity in US veterans with rheumatoid arthritis (RA). METHODS This historical cohort analysis evaluated patient visits from the V
Autor:
Jeffrey R. Curtis, Paul Emery, Greg Kricorian, Priscilla K. Yen, David H. Collier, Vivian Bykerk, Boulos Haraoui
Publikováno v:
The Journal of Rheumatology. :jrheum.2022-1008
ObjectiveSome patients with rheumatoid arthritis (RA) who persist in remission may decide to stop their therapy. We evaluated baseline characteristics associated with remaining in remission or low disease activity (LDA) following medication withdrawa
Autor:
Philip J. Mease, Dafna D. Gladman, Joseph F. Merola, Atul Deodhar, Alexis Ogdie, David H. Collier, Lyrica Liu, Arthur Kavanaugh
Publikováno v:
The Journal of rheumatology. 49(8)
ObjectiveIn this post hoc analysis, we examined the potential impact of sex and BMI on response in the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA) trial (NCT02376790), a 48-wee
Autor:
Philip J. Mease, Scott Stryker, Mei Liu, Sabrina Rebello, Mahdi Gharaibeh, David H. Collier, Bob Salim
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Arthritis Research & Therapy, Vol 23, Iss 1, Pp 1-13 (2021)
Background Understanding the evolving treatment patterns in patients with rheumatoid arthritis (RA) is important for rheumatologists to make the best practice decisions and optimize treatment. Here, we describe treatment patterns among patients newly
Objective Characterize psoriatic arthritis (PsA) heterogeneity and develop a conceptual framework to model the clinical and economic value of treatments on key PsA disease domains. Methods We performed a narrative literature review to identify the ke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f04bbb33753bf37b51d2c31a56b6fdba
https://doi.org/10.1101/2021.08.09.21261799
https://doi.org/10.1101/2021.08.09.21261799
Publikováno v:
Revista Brasileira de Reumatologia, Vol 43, Iss 5, Pp 294-301 (2003)
Patients with scleroderma are at increased risk for the development of pulmonary hypertension, and the development of unexplained dyspnea or an isolated decrease in diffusing capacity should prompt evaluation. Echocardiography is often helpful in thi
Externí odkaz:
https://doaj.org/article/8519b21c3aee45ada9a4353d14304deb